Systemic and local expression of perforin in lymphocyte subsets in acute and chronic rheumatoid arthritis

Journal of Rheumatology

Volumn 30, Issue 4, 2003, Pages 660-670

  Gulan, Gordan ^a   Ravlic Gulan, Jagoda ^a   Strbo, Natasa ^a   Sotosek, Vlatka ^a   Nemec, Boris ^a   Matovinovic, Damir ^a   Rubinic, Dusan ^a   Podack, Eckhard R ^b   Rukavina, Daniel ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Blood; Lymphocyte mediated cytotoxicity; Perforin; Rheumatoid arthritis; Synovial tissue

Indexed keywords

ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; PERFORIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CELL ASSAY; CELL POPULATION; CELL SURFACE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOLYSIS; CYTOPLASM; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; SYNOVIUM;

ACUTE DISEASE; AGED; ANTIGENS, CD56; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOARTHRITIS; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, IGG; RECEPTORS, INTERLEUKIN-2; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 12444279062     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
2. Fox RI, Fong S, Sabharwal N, Carstens SA, Kung PC, Vaughan JH. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol 1982;128:351-4.
3. Fort JG, Flanigan M, Smith JB. Mononuclear cell (MNC) subtypes in osteoarthritis synovial fluid. Comparison with MNC subtypes in rheumatoid arthritis synovial fluid. J Rheumatol 1995;22:1335-7.
4. Goto M, Miyamoto T, Nishioka K, Uchida S. T cytotoxic and helper cells are markedly increased, and T suppressor and inducer cells are markedly decreased, in rheumatoid synovial fluids. Arthritis Rheum 1987;30:737-43.
5. Cush JJ, Lipsky PE. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 1988;31:1230-8.
6. Kuryliszyn-Moskal A. Comparison of blood and synovial fluid lymphocyte subsets in rheumatoid arthritis and osteoarthritis. Clin Rheumatol 1995;14:43-50.
7. Duke O, Panayi GS, Janossy G, Poulter LW, Tidman N. Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies. Ann Rheum Dis 1983;42:357-61.
8. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121-5.
9. Podack ER, Dennert G. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 1983;302:442-5.
10. Young JD, Liu CC, Persechini PM, Cohn ZA. Perforin-dependent and -independent pathways of cytotoxicity mediated by lymphocytes. Immunol Rev 1988;103:161-202.
11. Jenne DE, Tschopp J. Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev 1988;103:53-71.
12. Bleackley RC, Lobe CG, Duggan B, et al. The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes. Immunol Rev 1988;103:5-19.
13. Griffiths GM, Mueller C. Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol Today 1991;12:415-9.
14. Yagita H, Nakata M, Kawasaki A, Shinkai Y, Okumura K. Role of perforin in lymphocyte-mediated cytolysis. Adv Immunol 1992;51:215-42.
15. Young LH, Peterson LB, Wicker LS, Persechini PM, Young JD. In vivo expression of perforin by CD8+ lymphocytes in autoimmune disease: Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice. J Immunol 1989;143:3994-9.
16. Nakamura H, Ebihara I, Tomino Y, Okumura K, Koide H. Perforin mRNA expression in the inflamed tissues of NZB/W F1 lupus mice decreases with methylprednisolone treatment. Am J Pathol 1991;139:731-6.
17. Smyth MJ, Ortaldo JR, Bere W, Yagita H, Okumura K, Young HA. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol 1990;145:1159-66.
18. Wu Z, Podack ER, McKenzie KJ, Olsen KJ, Zakarija M. Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease. Clin Exp Immunol 1994;98:470-7.
19. Rubesa G, Podack ER, Sepcic J, Rukavina D. Increased perforin expression in multiple sclerosis patients during exacerbation of disease in peripheral blood lymphocytes. J Neuroimmunol. 1997;74:198-204.
20. Muller-Ladner U, Kriegsmann J, Tschopp J, Gay RE, Gay S. Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:477-84.
21. Griffiths GM, Alpert S, Lambert E, McGuire J, Weissman IL. Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc Natl Acad Sci USA 1992;89:549-53.
22. Arnett FC, Edworthy SM, Bloch DA, et al. American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
23. Rukavina D, Rubesa G, Gudelj L, Haller H, Podack ER. Characteristics of perforin expressing lymphocytes within the first trimester decidua of human pregnancy. Am J Reprod Immunol 1995;33:394-404.
24. Smolen JS, Tohidast-Akrad M, Gal A, et al. The role of T-lymphocytes and cytokines in rheumatoid arthritis. Scand J Rheumatol 1996;25:1-4.
25. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;35:729-35.
26. Fox DA. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum 1997;40:598-609.
27. Carson DA. Unconventional T-cell activation by IL-15 in rheumatoid arthritis. Nature Med 1997;3:148-9.
28. Rukavina D, Laskarin G, Rubesa G, et al. Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood 1998;92:2410-20.
29. Young LH, Peterson LB, Wicker LS, Persechini PM, Young JD. In vivo expression of perforin by CD8+ lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice. J Immunol 1989;143:3994-9.
30. Young LH, Joag SV, Zheng LM, Lee CP, Lee YS, Young JD. Perforin-mediated myocardial damage in acute myocarditis. Lancet 1990;336:1019-21.
31. Griffiths GM, Namikawa R, Mueller C, et al. I. Granzyme A and perforin as markers for rejection in cardiac transplantation. Eur J Immunol 1991;21:687-93.
32. Rukavina D, Balen-Marunic S, Rubesa G, Orlic P, Vujaklija K, Podack ER. Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients. Transplantation 1996;61:285-91.
33. Miskovsky EP, Liu AY, Pavlat W, et al. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines. J Immunol 1994;153:2787-99.
34. Navarrete Santos A, Riemann D, Thiele K, Kehlen A, Navarrete Santos A, Langner J. Constitutive expression of HLA class II mRNA in synovial fibroblast-like cells from patients with rheumatoid arthritis. Immunol Letts 1997;58:53-8.
35. Spielman J, Lee RK, Podack ER. Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol 1998;161:7063-70.
36. Schubert J, Heiken H, Jacobs R, Delany P, Witte T, Schmidt RE. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function. Nat Immun Cell Growth Regul 1990;9:103-11.
37. Matsumoto I, Maccioni M, Lee DM, et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nature Immunol 2002;3:360-5.